Volume 54, Issue 4, Pages 1351-1356 (October 1998) Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation Diego Cantarovich, Georges Karam, Magali Giral-Classe, Maryvonne Hourmant, Jacques Dantal, Gilles Blancho, Loïc Le Normand, Jean-Paul Soulillou Kidney International Volume 54, Issue 4, Pages 1351-1356 (October 1998) DOI: 10.1046/j.1523-1755.1998.00094.x Copyright © 1998 International Society of Nephrology Terms and Conditions
Figure 1 Kaplan-Meier patient (A), pancreas (B), and kidney survival (C) rates after simultaneous pancreas-kidney (SPK) transplantation. Survival rates did not statistically differ (log rank test P < 0.9 for patient, 0.9 for pancreas and 0.3 for kidney survival, respectively) between patients receiving prophylactic antithymocyte globulin (ATG), azathioprine, corticosteroids and delayed introduction of cyclosporine A (CsA; ATG group), or triple therapy induction with immediate CsA, azathioprine and corticosteroids, without ATG (non-ATG group). Symbols are: ( ) ATG group; (— —) non-ATG group. Kidney International 1998 54, 1351-1356DOI: (10.1046/j.1523-1755.1998.00094.x) Copyright © 1998 International Society of Nephrology Terms and Conditions
Kidney International 1998 54, 1351-1356DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1351-1356DOI: (10.1046/j.1523-1755.1998.00094.x) Copyright © 1998 International Society of Nephrology Terms and Conditions
Kidney International 1998 54, 1351-1356DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1351-1356DOI: (10.1046/j.1523-1755.1998.00094.x) Copyright © 1998 International Society of Nephrology Terms and Conditions
Kidney International 1998 54, 1351-1356DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1351-1356DOI: (10.1046/j.1523-1755.1998.00094.x) Copyright © 1998 International Society of Nephrology Terms and Conditions